HS
HSOA.F Encompass Health Corporation
- Market cap
- EUR 12.4B
- P/E
- 23.4x
- P/B
- 5.19x
- ROE
- 24.8%
- Dividend yield
- 0.59%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is HSOA.F undervalued?
Graham numberHSOA.F trades 132.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Encompass Health Corporation fundamental analysis
No fundamental analysis for Encompass Health Corporation yet.
Encompass Health Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Encompass Health Corporation
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such…
Full company profileEncompass Health Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Encompass Health Corporation annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 3.65B | 3.92B | 4.28B | 4.61B | 4.64B | 5.12B | 4.35B | 4.80B | 5.37B | 5.94B | 6.39B |
| Gross Profit | 3.51B | 3.77B | 4.12B | 4.44B | 4.44B | 4.91B | 4.15B | 1.98B | 2.23B | 5.68B | 6.13B |
| Operating Income | 649M | 649M | 630M | 693M | 645M | 807M | 630M | 732M | 865M | 1.05B | 1.17B |
| EBITDA | - | 835M | 840M | 941M | 900M | 1.08B | 870M | 1.02B | 1.19B | 1.40B | 1.57B |
| Net Income | 248M | 256M | 292M | 359M | 284M | 412M | 271M | 352M | 456M | 566M | 664M |
| EPS | - | 2.61 | 2.95 | 3.64 | 2.86 | 4.14 | 2.72 | 3.51 | 4.52 | 5.66 | 6.76 |
| Balance Sheet | |||||||||||
| Total Assets | 4.68B | 4.89B | 5.18B | 6.08B | 6.45B | 6.86B | 5.64B | 6.10B | 6.53B | 7.09B | 7.57B |
| Total Liabilities | 3.75B | 3.47B | 3.62B | 4.39B | 4.48B | 4.47B | 3.77B | 3.81B | 3.69B | 3.81B | 4.01B |
| Shareholders' Equity | 736M | 1.18B | 1.28B | 1.35B | 1.59B | 1.91B | 1.31B | 1.65B | 2.07B | 2.44B | 2.68B |
| Cash & Short-term Investments | 40.5M | 54.4M | 69.2M | 94.8M | 224M | 54.8M | 21.8M | 69.1M | 85.4M | 72.2M | 76.2M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 640M | 658M | 762M | 635M | 705M | 716M | 706M | 822M | 1.00B | 1.18B | 1.28B |
| Capital Expenditure | 203M | 226M | 255M | 372M | 393M | 525M | 565M | 570M | 643M | 736M | 823M |
| Free Cash Flow | - | 412M | 492M | 231M | 297M | 165M | 122M | 252M | 360M | 439M | 454M |
| Ratios | |||||||||||
| ROE | 33.6% | 21.7% | 22.9% | 26.5% | 17.9% | 21.6% | 20.7% | 21.4% | 22.0% | 23.2% | 24.8% |
| ROA | 5.3% | 5.2% | 5.6% | 5.9% | 4.4% | 6.0% | 4.8% | 5.8% | 7.0% | 8.0% | 8.8% |
| Net Profit Margin | 6.8% | 6.5% | 6.8% | 7.8% | 6.1% | 8.0% | 6.2% | 7.3% | 8.5% | 9.5% | 10.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Encompass Health Corporation dividends
- Dividend yield
- 0.59%
- Forward dividend
- 0.75 EUR
- Payout ratio
- 12.6%
- Ex-dividend date
- Jan 4, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 71.1M | 0.71 | 12.6% |
| 2024 | USD 62.8M | 0.62 | 13.8% |
| 2023 | USD 60.4M | 0.60 | 17.2% |
| 2022 | USD 99.0M | 0.99 | 36.5% |
| 2021 | USD 112M | 1.13 | 27.2% |
| 2020 | USD 112M | 1.12 | 39.3% |
| 2019 | USD 109M | 1.10 | 30.3% |
| 2018 | USD 101M | 1.02 | 34.5% |
| 2017 | USD 91.5M | 0.93 | 35.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Encompass Health Corporation
- Insiders 0.87%
- Institutions 99.13%
- Public & others 0.00%
- Shares outstanding 98.1M
- Free float 97.1M
Encompass Health Corporation company profile
- Company name
- Encompass Health Corporation
- Ticker
- HSOA.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 29,875
- Fiscal year end
- December
- Address
- 9001 Liberty Parkway, Birmingham, AL, United States, 35242
- Phone
- 205 967 7116
- Website
- encompasshealth.com
About Encompass Health Corporation
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
Encompass Health Corporation management
10- Mr. Mark J. TarrCEO, President & Director · born 1962
- Mr. Douglas E. ColtharpExecutive VP & CFO · born 1962
- Mr. Patrick W. TuerExecutive VP & COO · born 1985
- Mr. John Patrick DarbyExecutive VP, General Counsel & Corporate Secretary · born 1965
- Dr. Elissa Joy Charbonneau D.O., M.S.Chief Medical Officer · born 1960
- Mr. Andrew L. PriceSenior VP & Chief Accounting Officer · born 1967
- Mr. Rusty YeagerChief Information Officer & Senior VP
- Mr. Mark MillerSenior Vice President of Investor Relations & Strategic Planning
- Ms. Dawn RockChief Compliance Officer
- Mr. Anthony A. HernandezChief Human Resources Officer · born 1966